These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 28940837)

  • 21. A Hematopoietic Stem Cell Transplant Recipient with Nephrotic Syndrome and Immune Complex Deposits in Tubular Basement Membrane: A Rare Case Report.
    Nematollahi N; Hakemi MS; Tavakoli F; Nili F
    Iran J Kidney Dis; 2023 Sep; 17(5):281-284. PubMed ID: 37838938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal Complications after Hematopoietic Stem Cell Transplantation: Role of Graft-Versus-Host Disease in Renal Thrombotic Microangiopathy.
    Mii A; Shimizu A; Yamaguchi H; Tsuruoka S
    J Nippon Med Sch; 2020 Mar; 87(1):7-12. PubMed ID: 31776318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late transplant-associated thrombotic microangiopathy verified in bone marrow biopsy specimens is associated with chronic GVHD and viral infections.
    Hill W; Sotlar K; Hautmann A; Kolb HJ; Ullmann J; Hausmann A; Schmidt M; Tischer J; Pham TT; Rank A; Hoechstetter MA
    Eur J Haematol; 2024 May; 112(5):819-831. PubMed ID: 38243840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy accompanied by renal arteriolar C4d deposition.
    Sakamoto K; Imamura T; Osone S; Nishimura A; Nishida M; Ishida H; Hosoi H
    Pediatr Transplant; 2015 Jun; 19(4):E97-100. PubMed ID: 25735190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
    Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
    Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membranous nephropathy after allogeneic stem cell transplantation: report of 2 cases.
    Tsutsumi C; Miyazaki Y; Fukushima T; Yoshida S; Taguchi J; Miyake C; Miyazaki M; Kohno S; Jinnai I; Tomonaga M
    Int J Hematol; 2004 Feb; 79(2):193-7. PubMed ID: 15005351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kidney injury in transplantation-associated thrombotic microangiopathy].
    Lu M; Zou WZ; Zhang Y; Wang SL; Wang W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):392-4. PubMed ID: 18677386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal.
    Oliveira JS; Bahia D; Franco M; Balda C; Stella S; Kerbauy J
    Bone Marrow Transplant; 1999 Jan; 23(1):99-101. PubMed ID: 10037059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series.
    Brinkerhoff BT; Houghton DC; Troxell ML
    Mod Pathol; 2016 Jun; 29(6):637-52. PubMed ID: 27015134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation.
    Yamada-Fujiwara M; Miyamura K; Fujiwara T; Tohmiya Y; Endo K; Onishi Y; Ishizawa K; Kameoka J; Ito M; Harigae H
    Tohoku J Exp Med; 2012 May; 227(1):31-7. PubMed ID: 22531159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal dysfunction following bone marrow transplantation.
    Kemmner S; Verbeek M; Heemann U
    J Nephrol; 2017 Apr; 30(2):201-209. PubMed ID: 27589851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membranous nephropathy is developed under Th2 environment in chronic graft-versus-host disease.
    Nakashima H
    Med Hypotheses; 2007; 69(4):787-91. PubMed ID: 17398013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.
    Postalcioglu M; Kim HT; Obut F; Yilmam OA; Yang J; Byun BC; Kupiec-Weglinski S; Soiffer R; Ritz J; Antin JH; Alyea E; Koreth J; Cutler C; Armand P; Paik JM; Leaf DE; Ho VT; Abdi R
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2344-2353. PubMed ID: 29758394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Membranous nephropathy with nephrotic syndrome developed after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia].
    Aimoto M; Yamane T; Ichii M; Mori K; Moriguchi-Aimoto R; Wada-Inoue E; Koh H; Nakane T; Takeoka Y; Akahori-Nakamae M; Nishiki-Kosaka S; Terada Y; Nakamae H; Koh KR; Nakao T; Ohsawa M; Wakasa K; Ishimura E; Inaba M; Hino M
    Rinsho Ketsueki; 2011 Jul; 52(7):556-62. PubMed ID: 21821990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?
    Brukamp K; Doyle AM; Bloom RD; Bunin N; Tomaszewski JE; Cizman B
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):685-94. PubMed ID: 17699273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membranous nephropathy in a bone marrow transplant recipient.
    Hiesse C; Goldschmidt E; Santelli G; Charpentier B; Machover D; Fries D
    Am J Kidney Dis; 1988 Feb; 11(2):188-91. PubMed ID: 3277409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation.
    Srinivasan R; Balow JE; Sabnis S; Lundqvist A; Igarashi T; Takahashi Y; Austin H; Tisdale J; Barrett J; Geller N; Childs R
    Br J Haematol; 2005 Oct; 131(1):74-9. PubMed ID: 16173966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.
    Kennedy GA; Kearey N; Bleakley S; Butler J; Mudie K; Durrant S
    Bone Marrow Transplant; 2010 Apr; 45(4):699-704. PubMed ID: 19767787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The genetic basis of post-bone marrow transplant thrombotic microangiopathy: is this the last piece of the puzzle?].
    Mancianti N; Guarnieri A; Tripodi S; Salvo DP; Rollo F; Lenoci M; Toraldo F; Bucalossi A; Garosi G
    G Ital Nefrol; 2022 Feb; 39(1):. PubMed ID: 35191626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.